DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories
02 1Baxter Healthcare Corporation
03 1Clinigen Group
04 5Eisai
05 5Eisai Inc
06 1GLAND PHARMA LIMITED
07 1JIANGXI QINGFENG
08 1Long Grove Pharmaceuticals
09 1Natco Pharma (Canada) Inc
01 1Eribulina 0.88Mg 2Ml 1 Units Parenteral Use
02 1INJ
03 1Inj Solution
04 1Injection
05 1Injection fluid, resolution
06 2SOLUTION
07 1SOLUTION FOR INJECTION
08 5SOLUTION;INTRAVENOUS
09 4Blank
01 1Lead Market Dossiers- Filed
02 1Originator
03 2Prescription
04 5RX
05 8Blank
01 4ERIBULIN MESYLATE
02 3HALAVEN
03 8Halaven
04 1NAT-ERIBULIN
05 1Blank
01 4Australia
02 2Canada
03 1India
04 1Italy
05 1Norway
06 1South Africa
07 1Sweden
08 1Switzerland
09 5USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 0.5MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2024-10-01
Application Number : 217250
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Halaven
Dosage Form : INJ
Dosage Strength : 100mg/ 5 ml
Packaging : 2X1mg/2ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info :
Registration Country : Switzerland
Brand Name : Halaven
Dosage Form : Inj Solution
Dosage Strength : 1mg/2ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Australia
Brand Name : Halaven
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Halaven
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Halaven
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Halaven
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info : RX
Registration Country : USA
Brand Name : HALAVEN
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2010-11-15
Application Number : 201532
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Sweden
Brand Name : HALAVEN
Dosage Form : SOLUTION FOR INJECTION
Dosage Strength : 0.44 MG / ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Italy
Brand Name : Halaven
Dosage Form : Eribulina 0.88Mg 2Ml 1 Units Parenteral Use
Dosage Strength : 1 vial EV 0.88 mg 2 ml 0.44 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Norway
Brand Name : Halaven
Dosage Form : Injection fluid, resolution
Dosage Strength : 0.44 mg/ml
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : HALAVEN
Dosage Form : SOLUTION
Dosage Strength : 0.5MG/ML
Packaging : 2ML
Approval Date :
Application Number : 2377438
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2024-04-05
Application Number : 218047
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2024-07-18
Application Number : 214850
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : NAT-ERIBULIN
Dosage Form : SOLUTION
Dosage Strength : 0.5MG/ML
Packaging :
Approval Date :
Application Number : 2539136
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2024-06-28
Application Number : 218281
Regulatory Info : RX
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?
